Direct Identification and Quantification of Recombinant Adeno-Associated Virus in Crude Cell Lysate and Conditioned Medium by Mass Photometry
Open Access
- 6 May 2025
- journal article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (19) , 10405-10416
Abstract
Recombinant adeno-associated virus (rAAV) has attracted attention as a gene therapy vector. Monitoring the percentage of full particles (FPs) to the sum of empty particles (EPs) and FPs (F/E ratio) is required to optimize the rAAV production conditions; however, there is a lack of analytical methods to identify FPs and EPs and quantify the F/E ratio of rAAV without purification. Here, we established a direct analysis method for identifying FPs and EPs and quantifying the F/E ratio and genomic titer of unpurified rAAV in crude cell lysate and conditioned medium by mass photometry (MP). MP can detect the events of both molecules that bind to the glass surface and molecules that unbind from the glass surface. Few unbinding molecules were detected in the cell lysate and conditioned medium, but unbinding particles were as prevalent as binding particles in rAAV. By analyzing the unbinding side of the histogram, the F/E ratio of rAAV in the cell lysate was directly quantified with accuracy comparable to that of purified rAAV, which showed there was no interference from impurities. The genomic titer of rAAV in cell lysate was also estimated using particle counts of the unbinding side. This method can successfully determine the F/E ratio and estimate genomic titers of rAAV in crude cell lysate and conditioned medium during the manufacturing process. Direct quantification by MP is a convenient, rapid, and accurate method for quantifying unpurified rAAV and will be useful for improving rAAV production processes, for example, by screening manufacturing conditions.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP18ae0201001, JP24se0123004h0101)
This publication has 41 references indexed in Scilit:
- Enhancing the production of adeno‐associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design‐of‐experiment optimization of triple plasmid ratioBiotechnology Journal, 2024
- High‐yield recombinant adeno‐associated viral vector production by multivariate optimization of bioprocess and transfection conditionsBiotechnology Progress, 2024
- Purity and DNA content of AAV capsids assessed by analytical ultracentrifugation and orthogonal biophysical techniquesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapiesMolecular Therapy - Methods & Clinical Development, 2021
- Improvements to the APBS biomolecular solvation software suiteProtein Science, 2017
- An Efficient Method for Estimating the Hydrodynamic Radius of Disordered Protein ConformationsBiophysical Journal, 2017
- Production of Recombinant Adeno‐Associated Viral Vectors and Use in In Vitro and In Vivo AdministrationCurrent Protocols in Neuroscience, 2011
- Comparative Protein Structure Modeling Using ModellerCurrent Protocols in Bioinformatics, 2006
- Competitive adsorption of model charged proteins: the effect of total charge and charge distributionJournal of Colloid and Interface Science, 2004
- Influence of surfactants upon protein/peptide adsorption to glass and polypropyleneInternational Journal of Pharmaceutics, 1995